Comparison of high-sensitivity C-reactive protein and fetuin-A levels before and after treatment for subjects with subclinical hyperthyroidism
dc.contributor.author | Bilgir, O | |
dc.contributor.author | Bilgir, F | |
dc.contributor.author | Topcuoglu, T | |
dc.contributor.author | Calan, M | |
dc.contributor.author | Calan, O | |
dc.date.accessioned | 2024-07-18T12:05:23Z | |
dc.date.available | 2024-07-18T12:05:23Z | |
dc.description.abstract | This study was designed to show the effect of propylthiouracil treatment on sCD40L, high-sensitivity C-reactive protein, and fetuin-A levels on subjects with subclinical hyperthyroidism. After checking sCD40L, high-sensitivity C-reactive protein, and fetuin-A levels of 35 patients with subclinical hyperthyroidism, each was given 50 mg tablets of propylthiouracil three times daily. After 3 months, sCD40L, high-sensitivity C-reactive protein, and fetuin-A levels were then compared to the levels before treatment. Although high-sensitivity C-reactive protein and sCD40L levels were normal in the subclinical hyperthyroidism patients compared to the healthy controls, fetuin-A levels were statistically significantly higher (*p = 0.022). After treatment, fetuin-A levels of subclinical hyperthyroidism patients decreased statistically significantly compared to the levels before treatment (**p = 0.026). sCD40L and high-sensitivity C-reactive protein levels did not have a statistically significant difference compared to the control group and post-propylthiouracil treatment. In subclinical hyperthyroidism patients, high fetuin-A levels before propylthiouracil treatment and decreases in these levels after treatment in cases with subclinical hyperthyroidism indicated the possibility of preventing long-term cardiac complications with propylthiouracil treatment. | |
dc.identifier.issn | 1355-008X | |
dc.identifier.other | 1559-0100 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/9727 | |
dc.language.iso | English | |
dc.publisher | SPRINGER | |
dc.subject | CORONARY-HEART-DISEASE | |
dc.subject | ALL-CAUSE MORTALITY | |
dc.subject | THYROID-DYSFUNCTION | |
dc.subject | BLOOD-PRESSURE | |
dc.subject | RISK | |
dc.subject | HORMONE | |
dc.subject | METAANALYSIS | |
dc.subject | ASSOCIATION | |
dc.subject | COMMUNITY | |
dc.title | Comparison of high-sensitivity C-reactive protein and fetuin-A levels before and after treatment for subjects with subclinical hyperthyroidism | |
dc.type | Article |